Tri Xenglu Xr 10mg/5mg/1000mg Tablet – Triple Combination for Type 2 Diabetes Control
Tri Xenglu Xr 10mg/5mg/1000mg Tablet – Triple Combination for Type 2 Diabetes Control
Description
Tri Xenglu Xr 10mg/5mg/1000mg Tablet – Extended-Release Therapy for Optimal Glycemic Management
Tri Xenglu Xr 10mg/5mg/1000mg Tablet is a prescription medication combining empagliflozin 10mg, linagliptin 5mg, and metformin hydrochloride extended-release 1000mg. This triple-action formula works synergistically to lower blood sugar levels in adults with type 2 diabetes: empagliflozin promotes glucose excretion through urine, linagliptin enhances insulin release while reducing glucagon, and metformin decreases liver glucose production and improves insulin sensitivity. As an extended-release tablet, it provides steady control throughout the day with convenient once-daily dosing, making it ideal for patients needing comprehensive management alongside diet and exercise. What sets this tablet apart is its multi-mechanism approach, which may reduce the risk of cardiovascular events in high-risk patients, supported by clinical studies showing effective A1C reduction without significant weight gain.
